Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-003286
Filing Date
2017-01-10
Accepted
2017-01-10 20:07:22
Documents
1
Period of Report
2017-01-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4061
  Complete submission text file 0001209191-17-003286.txt   5420
Mailing Address 1 N. WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address
LEONARD JOHN M. (Reporting) CIK: 0001563584 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37766 | Film No.: 17521790

Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Issuer) CIK: 0001652130 (see all company filings)

EIN.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances